IL128036A - Deoxynojirimycin derivatives comprising a polyclic alcohol group, pharmaceutical composition comprising a deoxynojirimycin derivative and uses thereof - Google Patents
Deoxynojirimycin derivatives comprising a polyclic alcohol group, pharmaceutical composition comprising a deoxynojirimycin derivative and uses thereofInfo
- Publication number
- IL128036A IL128036A IL12803697A IL12803697A IL128036A IL 128036 A IL128036 A IL 128036A IL 12803697 A IL12803697 A IL 12803697A IL 12803697 A IL12803697 A IL 12803697A IL 128036 A IL128036 A IL 128036A
- Authority
- IL
- Israel
- Prior art keywords
- deoxynojirimycin
- polyclic
- pharmaceutical composition
- alcohol group
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96202010 | 1996-07-15 | ||
PCT/NL1997/000411 WO1998002161A1 (en) | 1996-07-15 | 1997-07-14 | Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
IL128036A0 IL128036A0 (en) | 1999-11-30 |
IL128036A true IL128036A (en) | 2005-08-31 |
Family
ID=8224192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12803697A IL128036A (en) | 1996-07-15 | 1997-07-14 | Deoxynojirimycin derivatives comprising a polyclic alcohol group, pharmaceutical composition comprising a deoxynojirimycin derivative and uses thereof |
Country Status (9)
Country | Link |
---|---|
US (1) | US6177447B1 (xx) |
EP (1) | EP0912179B1 (xx) |
JP (5) | JP4564108B2 (xx) |
AT (1) | ATE322900T1 (xx) |
AU (1) | AU732552B2 (xx) |
CA (1) | CA2260790C (xx) |
DE (1) | DE69735669T2 (xx) |
IL (1) | IL128036A (xx) |
WO (1) | WO1998002161A1 (xx) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6098631A (en) * | 1998-01-21 | 2000-08-08 | The Regents Of The University Of Michigan | Compositions and methods for treating autoimmune disease |
US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
US6610703B1 (en) | 1998-12-10 | 2003-08-26 | G.D. Searle & Co. | Method for treatment of glycolipid storage diseases |
GB0100889D0 (en) | 2001-01-12 | 2001-02-21 | Oxford Glycosciences Uk Ltd | Compounds |
GB9909064D0 (en) * | 1999-04-20 | 1999-06-16 | Oxford Glycosciences Uk Ltd | Therapies |
GB9909066D0 (en) * | 1999-04-20 | 1999-06-16 | Oxford Glycosciences Uk Ltd | Therapies |
ATE234626T1 (de) | 1999-07-26 | 2003-04-15 | Searle & Co | Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin mit glucocerebrosidase enzyme zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten |
US7182953B2 (en) * | 1999-12-15 | 2007-02-27 | Celgene Corporation | Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
AU2001236713A1 (en) * | 2000-02-17 | 2001-08-27 | Genzyme Corporation | Methods for treatment of lysosomal storage diseases |
WO2001097829A2 (en) * | 2000-06-19 | 2001-12-27 | Genzyme Corporation | Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
US7138262B1 (en) * | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
US20030124160A1 (en) * | 2001-10-12 | 2003-07-03 | Petrescu Stefana M. | Targeted drug delivery |
EP1534676B1 (en) | 2002-07-17 | 2012-09-12 | Actelion Pharmaceuticals Ltd. | Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
JP4585851B2 (ja) | 2002-07-17 | 2010-11-24 | アクテリオン ファーマシューティカルズ リミテッド | グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体 |
GB0313677D0 (en) | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compound |
GB0313678D0 (en) | 2003-06-13 | 2003-07-16 | Oxford Glycosciences Uk Ltd | Novel compounds |
AU2004283631A1 (en) * | 2003-10-29 | 2005-05-06 | Genzyme Corporation | Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof |
EP1528056A1 (en) * | 2003-10-29 | 2005-05-04 | Academisch Ziekenhuis bij de Universiteit van Amsterdam | Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
BRPI0416217A8 (pt) * | 2003-11-12 | 2018-05-08 | Amicus Therapeutics Inc | composto derivado de hidroxipiperidina, métodos para a síntese de um composto derivado de hidroxipiperidina para inibir glicocerebrosidase, para aumentar a atividade de glicocerebrosidase numa célula de mamífero e para estabilizar glicocerebrosidade, composição farmacêutica, métodos para inibir beta-glicosidade, e para tratar doença de gaucher e derivado hidroxipiperidina com ligante flexível curto |
WO2005063706A1 (en) * | 2003-12-23 | 2005-07-14 | Macrozyme Dnm B.V. | Synthesis of nojirimycins |
US20090111812A1 (en) * | 2004-06-14 | 2009-04-30 | Musc Foundation For Research Development | Methods for treating inflammatory disorders |
ES2391657T3 (es) | 2006-02-07 | 2012-11-28 | Shire Human Genetic Therapies, Inc. | Composiciones estabilizadas de proteínas que tienen un resto tiol libre |
US8410081B2 (en) | 2006-04-24 | 2013-04-02 | Academisch Medisch Centrum | Treatment of cystic fibrosis |
US8546369B2 (en) * | 2008-05-30 | 2013-10-01 | Northern Innovations Holding Corp. | Salts of creatine imino sugar amides |
US20100248365A1 (en) * | 2009-03-27 | 2010-09-30 | Zacharon Pharmaceuticals, Inc. | Ganglioside biosynthesis modulators |
RU2733466C2 (ru) | 2009-07-28 | 2020-10-01 | Шайр Хьюман Дженетик Терапиз | Композиции и способы для лечения болезни гоше |
US9453847B2 (en) | 2010-07-19 | 2016-09-27 | Shire Human Genetic Therapies, Inc. | Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof |
KR20140138850A (ko) | 2012-03-02 | 2014-12-04 | 샤이어 휴먼 지네틱 테라피즈 인크. | Iii형 고셔병을 치료하기 위한 조성물 및 방법 |
JP2015518896A (ja) * | 2012-06-06 | 2015-07-06 | ユニザー ヴィロロジー,エルエルシー | 新規イミノ糖およびそれらの用途 |
WO2014017915A2 (en) | 2012-07-27 | 2014-01-30 | Universiteit Utrecht Holding B.V. | Urea and guanidinium derivatives of iminosugars |
DK3122726T3 (en) | 2014-03-27 | 2018-10-08 | Acad Medisch Ct | N- (5 - ((Aryl or heteroaryl) methyloxy) pentyl) -substituted imino sugars as inhibitors of glucosylceramide synthase |
EP3256116B1 (en) * | 2015-02-11 | 2022-08-17 | Icahn School of Medicine at Mount Sinai | Benzenesulfonamide upregulators of npc1 for neimann-pick disease and other lysosomal storage disorders |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2925943A1 (de) * | 1979-06-27 | 1981-01-29 | Bayer Ag | 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3007078A1 (de) * | 1980-02-26 | 1981-09-10 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung |
DE3024901A1 (de) | 1980-07-01 | 1982-01-28 | Bayer Ag, 5090 Leverkusen | Herbizide mittel auf basis von piperidin-derivaten |
DE3507019A1 (de) * | 1985-02-28 | 1986-08-28 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung |
US4880902A (en) | 1987-08-27 | 1989-11-14 | Shell Oil Company | Copolymerization of carbon monoxide and olefin with diphosphine having heterocyclic substituents as catalyst |
EP0350012A3 (en) * | 1988-07-08 | 1990-09-05 | Meiji Seika Kaisha Ltd. | Antiviral composition |
JPH02306962A (ja) * | 1989-05-19 | 1990-12-20 | Meiji Seika Kaisha Ltd | 新規n―置換―1―デオキシノジリマイシン誘導体及びそれを含有する癌細胞転移抑制剤 |
JP3162123B2 (ja) | 1990-09-20 | 2001-04-25 | モンサント カンパニー | N−置換−1−デオキシノジリマイシンの製造方法 |
AU5743994A (en) * | 1992-12-10 | 1994-07-04 | Enzon, Inc. | Glycolipid enzyme-polymer conjugates |
US5429177A (en) | 1993-07-09 | 1995-07-04 | Sierra Regenators, Inc. | Foil regenerator |
WO1995022975A1 (en) * | 1994-02-25 | 1995-08-31 | G.D. Searle & Co. | Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
-
1997
- 1997-07-14 EP EP97930879A patent/EP0912179B1/en not_active Expired - Lifetime
- 1997-07-14 US US09/230,005 patent/US6177447B1/en not_active Expired - Lifetime
- 1997-07-14 AU AU34647/97A patent/AU732552B2/en not_active Expired
- 1997-07-14 IL IL12803697A patent/IL128036A/xx not_active IP Right Cessation
- 1997-07-14 DE DE69735669T patent/DE69735669T2/de not_active Expired - Lifetime
- 1997-07-14 WO PCT/NL1997/000411 patent/WO1998002161A1/en active IP Right Grant
- 1997-07-14 JP JP50587698A patent/JP4564108B2/ja not_active Expired - Lifetime
- 1997-07-14 AT AT97930879T patent/ATE322900T1/de not_active IP Right Cessation
- 1997-07-14 CA CA002260790A patent/CA2260790C/en not_active Expired - Lifetime
-
2009
- 2009-11-18 JP JP2009262461A patent/JP2010031062A/ja not_active Withdrawn
-
2013
- 2013-10-04 JP JP2013208841A patent/JP2014024857A/ja not_active Withdrawn
-
2016
- 2016-01-14 JP JP2016004873A patent/JP2016056203A/ja not_active Withdrawn
-
2017
- 2017-04-18 JP JP2017081926A patent/JP2017122133A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2260790C (en) | 2007-01-09 |
JP4564108B2 (ja) | 2010-10-20 |
DE69735669T2 (de) | 2007-03-29 |
EP0912179B1 (en) | 2006-04-12 |
JP2016056203A (ja) | 2016-04-21 |
CA2260790A1 (en) | 1998-01-22 |
JP2017122133A (ja) | 2017-07-13 |
EP0912179A1 (en) | 1999-05-06 |
JP2000516577A (ja) | 2000-12-12 |
ATE322900T1 (de) | 2006-04-15 |
DE69735669D1 (de) | 2006-05-24 |
IL128036A0 (en) | 1999-11-30 |
US6177447B1 (en) | 2001-01-23 |
JP2014024857A (ja) | 2014-02-06 |
AU732552B2 (en) | 2001-04-26 |
WO1998002161A1 (en) | 1998-01-22 |
AU3464797A (en) | 1998-02-09 |
JP2010031062A (ja) | 2010-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL128036A (en) | Deoxynojirimycin derivatives comprising a polyclic alcohol group, pharmaceutical composition comprising a deoxynojirimycin derivative and uses thereof | |
HUP9901304A3 (en) | Piperazine and piperidine derivatives with analgesic effect, process for their preparation and pharmaceutical compositions containing them | |
CA2209167A1 (en) | Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof | |
MX9603520A (es) | Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso. | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
GEP19991706B (en) | (54) Heteroarylpiperidines, Pyrrolidines and Piperazines and Their Use As Antipsychotics and Analgetics | |
CA2289717A1 (en) | Novel therapy for constipation | |
RU94040170A (ru) | Изохинолины | |
GB8904163D0 (en) | Piperazine derivative or its sait,process for producing the same and pharmaceutical composition comprising the same as active ingredient | |
CA2047744A1 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
HUP0004282A2 (hu) | 2-Halogén-6-0-szubsztituált ketolidszármazékok | |
NO980215L (no) | Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater | |
CA2163197A1 (en) | Tri(platinum) complexes | |
HUP9901260A3 (en) | Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate | |
DE60121431D1 (de) | Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe | |
DE69631542D1 (de) | Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen | |
NO982863L (no) | Nye forbindelser med analgetisk effekt | |
HUP9800707A3 (en) | Phenoxymethyl piperidine derivatives, process for producing them, and pharmaceutical compositions containing them | |
FR2726267B1 (fr) | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer | |
MA26745A1 (fr) | Diphosphate d'un derive de 9-deoxo-9a-aza-9a-homoerythromycine substituee en 4", son procede de preparation et composition pharmaceutique le contenant | |
HRP960063B1 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them | |
HUT50633A (en) | Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives | |
AU2287197A (en) | Heterocyclic compounds and their preparation and use | |
MA26556A1 (fr) | Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant. | |
NO943826D0 (no) | Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
HP | Change in proprietorship |
Owner name: MECROZYME DNM B.V. Free format text: FORMER OWNER:UNIVERSITEIT VAN AMSTERDAM |
|
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |